|
Captions are given in related document.
May 23th 2013 An actual company profile was published in the new edition of the "15th Guide to German Biotech Companies".
Company profile
April 18th 2013 The new biotechnology report from Ernst & Young is published. There you can find an article about the capability of Enzymicals. Document
June 18th 2012 Braun Beteiligungs GmbH (BBG) has acquired a stake in Enzymicals AG to facilitate a stronger collaboration between Enzymicals AG, Herbrand PharmaChemicals GmbH and BRAIN AG. Document - Image
February 28th 2012 Enzymicals AG forged links in Philadelphia within a marketing aid program of the German Federal Ministry of Economics. Document - Image
January 17th 2012 Enzymicals AG and Herbrand PharmaChemicals GmbH cooperate for biotechnological production of pharmaceuticals and intermediates. Document - Image 1 - Image 2
June 21st 2011 Enzymicals AG and Lonza AG sign license agreement for the global use of (R)-selective transaminases in laboratory scale in Lonza patented processes. Document - Image 1 - Image 2
June 1st 2011 White meets blue. Enzymicals AG and the Institute of Marine Biotechnology e.V. are going to cooperate in the areas of white and blue biotechnology. Document - Image 1
October 4th 2010 Enzymicals AG acquires proprietary rights on pig liver esterases (PLE) from Evonik AG. Document - Image 1
July 12th 2010 BRAIN AG acquires share in chemical and biocatalyst specialist Enzymicals AG. Document - Image 1 - Image 2 - Image 3
Enzymicals in the media
transkript 8-9/2012 The Brainzymicalsbraun AG Article (available in German)
ChemBioTec Review 003 Company profile Article (available in German)
transkript 8-9/2010 BRAIN invests in fine chemicals specialist Article (available in German)
BIOspektrum 06.10 Enzymicals AG: Academic spin-off with high ambitions Article (available in German)
|